FARMSON PHARMACEUTICAL
FARMSON PHARMACEUTICAL, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and specialty medicines. Founded in 1994, the company has established a strong presence in various operational regions, focusing on both domestic and international markets. With a diverse portfolio that includes formulations across multiple therapeutic areas, FARMSON is recognised for its commitment to quality and innovation. The company’s core products, which range from injectables to oral medications, are distinguished by their rigorous adherence to international standards and regulatory compliance. FARMSON PHARMACEUTICAL has achieved significant milestones, including certifications from leading global regulatory bodies, positioning itself as a trusted partner in healthcare. Its dedication to research and development further solidifies its market position, making it a key contributor to the pharmaceutical landscape in India and beyond.
DitchCarbon Score
How does FARMSON PHARMACEUTICAL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FARMSON PHARMACEUTICAL's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
FARMSON PHARMACEUTICAL's reported carbon emissions
FARMSON PHARMACEUTICAL, headquartered in India, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As FARMSON PHARMACEUTICAL navigates this landscape, it may consider establishing measurable goals and reporting on emissions to align with industry standards and enhance its climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FARMSON PHARMACEUTICAL is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
